跳至主要内容
临床试验/JPRN-jRCTs061180091
JPRN-jRCTs061180091已完成2 期

Effect of 0.01% atropine eye drops on myopia progression and axial elongation in children with moderate to high grade myopia - EACHAM

Hasebe Satoshi0 个研究点目标入组 18 人开始时间: 2019年3月22日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

This study suggests that the treatment of 0.01% atropine eye drops is effective in slowing myopia progression in children with moderate to high-grade myopia.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 6age old 至 <= 12age old(—)
性别
All

入选标准

  • 1.Age at base line: 5-12 years
  • 2.Spherical equivalent under cycloplegia: both eyes from -4.50 to -9.00D
  • 3.Aniseiconia =<1.50 D
  • 4.Astigmatism =<1.50 D
  • 5.Best corrected visual acuity = or >1.0
  • 6.Inter ocular pressure = or <21mmHg
  • 7.Willing to undergo cycloplegia
  • 8.Written informed consent by the child and parent

排除标准

  • 1.Abnormal binocular function
  • 2.Amblyopia or manifest strabismus
  • 3.Anisometropia >1.00D
  • 4.Eye diseases besides myopia
  • 5.ophthalmic and/or systematic diseases that may influence on visual acuity or refractive error
  • 6.Previous history of using atropine, contact lenses, bifocal or progressive addition lenses, or ortho-K
  • 7.Eye or general diseases that may affect myopia progression
  • 8.History of asthma treatment within 1 year.
  • 9.Allergic history to atropine, cyclopentolate, or benzalkonium
  • 10.Difficult to use eye drops
  • 11.A plan to use contact lenses

研究者

发起方
Hasebe Satoshi

相似试验